Montserrat Romera Baurés

ORCID: 0000-0003-1374-7640
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bone health and osteoporosis research
  • Osteoarthritis Treatment and Mechanisms
  • Rheumatoid Arthritis Research and Therapies
  • Musculoskeletal pain and rehabilitation
  • Systemic Lupus Erythematosus Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Inflammatory mediators and NSAID effects
  • Bone Metabolism and Diseases
  • Spondyloarthritis Studies and Treatments
  • Hip and Femur Fractures
  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Tuberculosis Research and Epidemiology
  • Autoimmune and Inflammatory Disorders Research
  • Bone and Joint Diseases
  • Nutritional Studies and Diet
  • Hip disorders and treatments
  • Eosinophilic Disorders and Syndromes
  • Myofascial pain diagnosis and treatment
  • Cholesterol and Lipid Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Musculoskeletal Disorders and Rehabilitation
  • Medical and Biological Sciences
  • Inflammasome and immune disorders
  • Histiocytic Disorders and Treatments

Olive Quimica (Spain)
2024

Universitat Internacional de Catalunya
2023

Bellvitge University Hospital
2007-2021

Institut d'Investigació Biomédica de Bellvitge
2007-2019

Collaborative Group (United States)
2016

Ajuntament de L’Hospitalet
2005

Jordan University of Science and Technology
2001-2002

USP Institut Universitari Dexeus
2002

Universitat de Barcelona
1992

Institut Català de la Salut
1992

Carmen García‐Gómez María A. Martín‐Martínez Santos Castañeda Fernando Sánchez‐Alonso Miren Uriarte-Ecenarro and 95 more Carlos González‐Juanatey Montserrat Romera Baurés José Santos-Rey José Antonio Pinto-Tasende Estefanía Quesada‐Masachs Jesús Tornero-Molina Olga Martínez González Tatiana Cobo‐Ibáñez Eugenio Chamizo-Carmona Sara Manrique‐Arija Dolores Fábregas-Canales Federico Díaz‐González Javier Llorca Miguel Á. González‐Gay Eugenia Gonzalez de Rábago Elena Alonso Blanco Morales J. Carlos Fernández López Natividad Oreiro Villar Antonio Atanes Sandoval Francisco J. Blanco Cayetano Alegre de Miquel Maria J Fernandez Ramón Huguet Codina Beatriz Yoldi Mercedes Ramentol G. Ávila Sara Marsal Barril Martina Steiner Santiago León Atehortúa Muñoz Fernando Gamero José García Torón María Pilar Gil Antonio Juan Más Pilar Espiño Inmaculada Ros Mónica Ibáñez Claudia Murillo José A. Piqueras Raimón Sanmartí Horacio Berman Sonia Cabrera Virginia Ruiz‐Esquide Oscar Fontseré Patón Benjamín Gutiérrez Lydia Abásolo María D. Fábregas Joan M. Nolla Miriam García Arias Alberto García-Vadillo Rosario García‐Vicuña Antonio Fernández‐Nebro María Angeles Belmonte López Inmaculada Ureña‐Garnica María Victoria Irigoyen V. Coret Cagigal Ruth López González Daniel Pielfort Garrido Juana Sampedro Álvarez Ángel María García Aparicio Rebeca Belmonte Gómez Pastora Granados Bautista Azucena Hernández Sanz Carmen Olga Sánchez González Javier Bachiller‐Corral Antonio Zea Francisco Javier Gutiérrez‐Mañero F. Jiménez Zorzo Eugenio Giménez Úbeda J. M. Álvaro Gracia Chesús Beltrán Audera Marta Medrano Ángela Pecondón Celia Erausquin Soledad Ojeda Juan Carlos Quevedo Félix Francisco Carlos Rodríguez Lozano Jesús Babío Herráez Francisco Javier López Longo D. Gerona Carlos González Luis Carreño I. Monteagudo Javier del Pino María Dolores Sánchez González Alfonso Corrales María Enriqueta Peiró José Gallego J. Rosas Isabel Rotés E. Moreno Alba Erra Dolors Grado Javier Calvo Amalia Rueda

10.1016/j.jacl.2017.02.018 article EN Journal of clinical lipidology 2017-03-16

Objective.The aim of this study was to develop a genetic prognostic tool predict radiographic progression towards severe disease in primary knee OA (KOA) patients.Methods.This investigation cross-sectional, retrospective, multicentric association 595 Spanish KOA patients.Caucasian patients aged 540 years at the time diagnosis KellgrenLawrence grade 2 or 3 were included.Patients who progressed score 4 referred for total replacement within 8 after classified as progressors disease.Clinical...

10.1093/rheumatology/keu478 article EN Lara D. Veeken 2015-01-07

Abstract Background Globally, osteoarthritis (OA) is the third condition associated with disability. There still poor treatment in OA but science holds key to finding better treatments and a cure. It essential learn what’s important patients from them implement most effective management. The Patients Task Force, conducted Global Patient Perception Survey (GOAPPS)-the first global survey made by analize quality of life (QoL) & patient perceptions care. goal was collect data on patients’...

10.1186/s12891-020-03741-0 article EN cc-by BMC Musculoskeletal Disorders 2020-11-07

To determine cardiovascular (CV) mortality and incidence of the first CV event (CVE) in patients with chronic inflammatory rheumatic diseases (CIRD) after 5 years follow-up.This is an analysis CARdiovascular rheMAatology (CARMA) study follow-up. It includes RA (n = 775), AS 738) PsA 721), individuals without CIRD 677) attending outpatient rheumatology clinics from 67 public hospitals Spain. Descriptive analyses were performed for at years. The Systematic COronary Risk Evaluation (SCORE)...

10.1093/rheumatology/keaa737 article EN Lara D. Veeken 2020-10-22

10.1016/j.reuma.2018.02.011 article ES Reumatología Clínica 2018-03-09

10.1016/j.reuma.2018.12.001 article ES Reumatología Clínica 2019-01-02

<h3>Background:</h3> Rheumatisms are the second most frequent reason for consultation in Europe [1]. In Spain, bulk of prevalence studies exploit public health data [2-3], despite fact that our system is mixed. Spanish private spending reaches 26.7% total and booming [4]. However, there a fundamental lack focused on care, which local [5-6]. <h3>Objectives:</h3> To characterise activity performed by rheumatologists medicine throughout geography. <h3>Methods:</h3> Members SERPA working group...

10.1136/annrheumdis-2024-eular.3402 article EN Annals of the Rheumatic Diseases 2024-06-01

<h3>Background</h3> Clinical studies have demonstrated that osteoarthritic pain is linked to disability and quality of life (QoL). The therapeutic modalities in the treatment osteoarthritis (OA) are numerous despite availability evidence-based guidelines for OA management, agreement on treatments lacking<sup>1</sup>. Symptomatic Slow-Acting Drugs (SYSADOA), natural compounds, used treatment. Thus, there disagreement about SYSADOAs use clinical practice. <h3>Objectives</h3> Our objective was...

10.1136/annrheumdis-2019-eular.4193 article EN Annals of the Rheumatic Diseases 2019-06-01

Background: The Mediterranean diet (MD) has proven beneficial in a large number of chronic diseases. relationship between the MD and rheumatic diseases is complex there are few studies that have studied this relationship. These show could be positive association adherence to (MD-A) lower prevalence OA. In case RA, it been proposed reduce pain improve functionality. Objectives: To determine MD-A patients with RA OA, compare healthy subjects. Methods: Multicenter, cross-sectional,...

10.1136/annrheumdis-2020-eular.3336 article EN Annals of the Rheumatic Diseases 2020-06-01
Coming Soon ...